Rezolute , Inc. (NASDAQ:RZLT), a clinical-stage biopharmaceutical company, is making significant strides in the development ...

Adding probiotics to antipsychotic treatment is associated with a significant decrease in schizophrenia symptoms, a new ...

At the Envision Summit 2025 in San Juan, Puerto Rico, Deepak Sambhara, MD, gave insight into the 96-week post hoc fluid ...

The "Sinusitis Pipeline Insight Analysis Report" drug pipelines has been added to ResearchAndMarkets.com's offering.The sinusitis treatment pipeline analysis provides an overview of recent ...

Enanta Pharmaceuticals, Inc. (NASDAQ:ENTA), a biotechnology company focused on developing small molecule drugs for viral infections and liver diseases, is navigating a critical phase in its evolution.

Altimmune's existence depends almost entirely on the outcome of the Phase 2 trial for pemvidutide in MASH. Learn why ALT ...

The Calgary Stroke Program, a joint University of Calgary and Alberta Health Services initiative at Foothills Medical Centre, has been involved with three papers published this week in The Lancet and ...

Targeted Variable Analysis: Identify hard-to-detect combinations ... Delivering Key Benefits for Your Trials Enhanced Efficacy: Optimize key clinical endpoints with high effect-size models for ...

Virtual reality technology is linked to greater motor rehabilitation improvements in critically ill patients than traditional ...

By transforming clinical trial data into actionable insights ... by assessing stability and variability across patient populations. Targeted Variable Analysis: Identify hard-to-detect combinations of ...

Targeted Variable Analysis: Identify hard-to-detect combinations of key ... Delivering Key Benefits for Your Trials Enhanced Efficacy: Optimize key clinical endpoints with high effect-size models for ...

This drive for improvement has seen the emergence of Sub-population Optimisation & Modelling Solutions (SOMS), a new approach to clinical trial methodology and analysis that harnesses the power of ...